CIK 0001555279 · Non-accelerated filer<br>Smaller reporting company
908 Devices Inc.
Sign in to watch- Ticker
- MASS
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454524096
- Phone
- 978-729-4478
- Business address
- 44 THIRD AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,701,292
- in 10 filings, $1.7M under 10b5-1 plans
Net −$2,701,292. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AWM Investment Company, Inc. −$1.0M 10% owner sold 2% of stake
- Brown Christopher D. −$1.0M Director sold 10% of stake
- Kenneweg John −$280K SVP, Sales & Product Marketing sold 32% of stake
- Knopp Kevin J. −$207K President and CEO sold 3% of stake
- Griffith Joseph H. IV −$191K Chief Financial Officer sold 12% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-09 | Brown Christopher D. Director | Sale 10b5-1 | −7,392 | $7.04 | $52K | 963,137 |
| 2026-04-08 | McCallion Kevin J. SVP, Products and Production | Option exercise 10b5-1 | +18,580 | $1.05 | $20K | 63,505 |
| 2026-04-08 | McCallion Kevin J. SVP, Products and Production | Sale 10b5-1 | −18,580 | $7.05 | $131K | 44,925 |
| 2026-04-08 | McCallion Kevin J. SVP, Products and Production | Option exercise · Stock Option (right to buy) 10b5-1 | −18,580 | 8,106 | ||
| 2026-04-08 | Brown Christopher D. Director | Sale 10b5-1 | −15,030 | $7.05 | $106K | 970,529 |
| 2026-03-02 | McCallion Kevin J. SVP, Products and Production | Option exercise 10b5-1 | +7 | $1.05 | $7 | 44,932 |
| 2026-03-02 | McCallion Kevin J. SVP, Products and Production | Sale 10b5-1 | −7 | $7.00 | $49 | 44,925 |
| 2026-03-02 | McCallion Kevin J. SVP, Products and Production | Option exercise · Stock Option (right to buy) 10b5-1 | −7 | 26,686 | ||
| 2026-03-02 | McCallion Kevin J. SVP, Products and Production | Sale 10b5-1 | −7 | $7.00 | $49 | 44,918 |
| 2026-02-02 | Knopp Kevin J. President and CEO | Sale | −34,764 | $6.18 | $215K | 795,968 |
| 2026-02-02 | Knopp Kevin J. President and CEO | Grant or award · Restricted Stock Units | +205,978 | 205,978 | ||
| 2026-02-02 | Knopp Kevin J. President and CEO | Grant or award · Stock Option (option to buy) | +90,043 | 90,043 | ||
| 2026-02-02 | Griffith Joseph H. IV Chief Financial Officer | Sale | −23,175 | $6.18 | $143K | 139,896 |
| 2026-02-02 | Griffith Joseph H. IV Chief Financial Officer | Grant or award · Restricted Stock Units | +121,164 | 121,164 | ||
| 2026-02-02 | Griffith Joseph H. IV Chief Financial Officer | Grant or award · Stock Option (option to buy) | +52,967 | 52,967 | ||
| 2026-02-01 | Brown Christopher D. Director | Option exercise | +5,027 | 967,149 | ||
| 2026-02-01 | Brown Christopher D. Director | Option exercise | +7,418 | 974,567 | ||
| 2026-02-01 | Brown Christopher D. Director | Option exercise | +10,992 | 985,559 | ||
| 2026-02-01 | Brown Christopher D. Director | Option exercise · Restricted Stock Units | −5,027 | 0 | ||
| 2026-02-01 | Brown Christopher D. Director | Option exercise · Restricted Stock Units | −7,418 | 7,418 |
Page 6 of 15 · 284 trades